Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Oryzon Genomics (ORY SM)
Watchlist
54
Analysis
Health Care
•
Spain
Oryzon Genomics, SA is a clinical stage biopharmaceutical company that develops epigenetics-based therapeutics.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Oryzon Genomics
•
19 Jan 2023 00:20
•
Issuer-paid
Oryzon Genomics - First Phase II patient enrolled is clinical milestone
Oryzon Genomics has announced that it has enrolled the first patient into its collaborative Phase II trial investigating the use of its lead LSD1...
Edison Investment Research
Follow
196 Views
Share
bullish
•
Oryzon Genomics
•
16 Dec 2022 19:56
•
Issuer-paid
Oryzon Genomics - Lead asset granted expansion into combo therapies
Oryzon Genomics has announced that it has been awarded an EU grant to initiate a project to investigate the company’s lead clinical oncology asset,...
Edison Investment Research
Follow
677 Views
Share
bullish
•
Oryzon Genomics
•
13 Dec 2022 16:18
•
Issuer-paid
Oryzon Genomics - Positive ALICE readouts pave way in AML
Oryzon Genomics has presented the top-line results of its Phase IIa ALICE trial investigating its lead oncology LSD1 inhibitor iadademstat in...
Edison Investment Research
Follow
678 Views
Share
bullish
•
Oryzon Genomics
•
09 Nov 2022 20:08
•
Issuer-paid
Oryzon Genomics - IND granted for collaborative Phase II trial
Oryzon Genomics announced that it has received FDA investigational new drug (IND) approval for the initiation of a collaborative Phase II trial...
Edison Investment Research
Follow
14 Views
Share
bullish
•
Oryzon Genomics
•
03 Nov 2022 19:00
•
Issuer-paid
Oryzon Genomics - Clinical ramp in Q3; several catalysts approaching
Oryzon Genomics reported Q322 results that are largely in line with our expectations. The clinical ramp up of its key assets, iadademstat and...
Edison Investment Research
Follow
298 Views
Share
First
Previous
3
4
5
6
7
8
9
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x